category,datetime,headline,id,image,related,source,summary,url
company,1769031000,"STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026",138199109,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,STE,Yahoo,"DUBLIN, IRELAND, Jan. 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 third quarter results at 9:00 a.m. ET on February 5, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will b",https://finnhub.io/api/news?id=c80cdcaf516028079ec56e0778478afbe9aa2602c1d48c76277b53ebfaac5745
company,1769014980,Steris PLC stock underperforms Wednesday when compared to competitors despite daily gains,138218209,,STE,MarketWatch,Steris PLC stock underperforms Wednesday when compared to competitors despite daily gains,https://finnhub.io/api/news?id=b3b874d0be49eb26e0df7ab4cb2cf8f3774ad6de23e455e9ebad8b6529b83c3b
company,1769010540,"CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February",138197266,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,STE,Yahoo,CAPR said the FDA wants the full HOPE-3 study report for Deramiocel and confirmed no new clinical trials are needed.,https://finnhub.io/api/news?id=663b3ba51288ecd86ac290f16bcacb8cddb77e6dde8bf7c7ff2a3208870482b2
company,1769000280,Here's Why You Should Retain Revvity Stock in Your Portfolio for Now,138196111,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,STE,Yahoo,"Revvity's diagnostics strength and fast-growing Signals Software support long-term growth, even as macro pressures and weak funding linger.",https://finnhub.io/api/news?id=4177e47e8904d6ec193b990e19d0ee98bd4ce2b2a56e4bc5bc0fc0f90f32d649
